Generic Name and Formulations:
Oxymetazoline HCl 1%; crm.
Indications for RHOFADE:
Persistent facial erythema associated with rosacea.
≥18yrs: apply a pea-sized amount once daily in a thin layer to entire face (forehead, nose, each cheek, chin). Wash hands after use.
<18yrs: not established.
Not for oral, ophthalmic, or intravaginal use. Avoid eyes, lips, irritated skin, or open wounds. Severe or unstable/uncontrolled cardiovascular disease. Orthostatic hypotension. Uncontrolled hypertension or hypotension. Cerebral or coronary insufficiency. Raynaud's phenomenon. Thromboangiitis obliterans. Scleroderma. Sjögren's syndrome. Increased risk of angle closure glaucoma. Pregnancy. Nursing mothers.
Caution with concomitant beta-blockers, antihypertensives, cardiac glycosides, alpha-1 receptor antagonists. Concomitant MAOIs may affect the metabolism and uptake of circulating amines; caution.
Application site reactions (eg, dermatitis, pruritus, erythema, pain), worsening inflammatory lesions of rosacea.
Gel—30g, 60g (tube or pump)
Neurology Advisor Articles
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Congress Passes Bill to Fight Opioid Crisis
- Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis
- Review of Factors Impacting Sport-Related Concussion Headaches
- Anodal tDCS Offers Possible Benefit for Improving Item Recall in Post-Stroke Aphasia
- Hospitalization Tied to Brain Abnormalities in Older Adults
- Spending Often Persists in High-Cost Medicare-Medicaid Eligible
- Skills-Based Intervention Did Not Cut Systolic BP After Stroke, TIA
- High Frequency of Headaches Following Dialysis Associated With BUN and Blood Pressure